Showing 37–45 of 45 results

Show sidebar
Show 9 12 18 24
Placeholder
Compare

Venclexta 10 mg Alternative – Venclax (Venetoclax) 10 mg Tablet | Beacon Pharmaceuticals

Venclax 10 mg (Venetoclax) Tablet by Beacon Pharmaceuticals. Reference brand: Venclexta. BCL-2 inhibitor; used in selected chronic lymphocytic leukemia and acute myeloid leukemia. Prescription medicine. Brand comparison does not establish interchangeability.

Add to wishlist
Read more
Quick view
Beacon Venclax venetoclax 100 mg box photographed by Onco Solution
Compare

Venclexta 100 mg Alternative – Venclax (Venetoclax) 100 mg Tablet | Beacon Pharmaceuticals

Venclax 100 mg (Venetoclax) Tablet by Beacon Pharmaceuticals. Reference brand: Venclexta. BCL-2 inhibitor; used in selected chronic lymphocytic leukemia and acute myeloid leukemia. Prescription medicine. Brand comparison does not establish interchangeability.

Add to wishlist
Read more
Quick view
Placeholder
Compare

Votrient 200 mg Alternative – Zopanib (Pazopanib) 200 mg Tablet | Beacon Pharmaceuticals

Zopanib 200 mg (Pazopanib) Tablet by Beacon Pharmaceuticals. Reference brand: Votrient. multikinase inhibitor; used in selected advanced renal cell carcinoma and soft tissue sarcoma. Prescription medicine. Brand comparison does not establish interchangeability.

Add to wishlist
Read more
Quick view
Placeholder
Compare

Votrient 400 mg Alternative – Zopanib (Pazopanib) 400 mg Tablet | Beacon Pharmaceuticals

Zopanib 400 mg (Pazopanib) Tablet by Beacon Pharmaceuticals. Reference brand: Votrient. multikinase inhibitor; used in selected advanced renal cell carcinoma and soft tissue sarcoma. Prescription medicine. Brand comparison does not establish interchangeability.

Add to wishlist
Read more
Quick view
Placeholder
Compare

Xalkori 250 mg Alternative – Alkriz (Crizotinib) 250 mg Tablet | Beacon Pharmaceuticals

Alkriz 250 mg (Crizotinib) Tablet by Beacon Pharmaceuticals. Reference brand: Xalkori. ALK/ROS1 kinase inhibitor; used in molecularly selected non-small cell lung cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Add to wishlist
Read more
Quick view
Beacon Xitabin 500 mg Capecitabine Original Packaging
Compare

Xeloda 500 mg Alternative – Xitabin (Capecitabine) 500 mg Tablet | Beacon Pharmaceuticals

Xitabin 500 mg (Capecitabine) Tablet by Beacon Pharmaceuticals. Reference brand: Xeloda. oral fluoropyrimidine chemotherapy; used in selected colorectal and breast cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Add to wishlist
Read more
Quick view
Beacon Zaluta 40 mg enzalutamide official packaging
Compare

Xtandi 40 mg Alternative – Zaluta (Enzalutamide) 40 mg Tablet | Beacon Pharmaceuticals

Zaluta 40 mg (Enzalutamide) Tablet by Beacon Pharmaceuticals. Reference brand: Xtandi. androgen receptor inhibitor; used in selected advanced prostate cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Add to wishlist
Read more
Quick view
Beacon Nirova 100 mg niraparib original packaging
Compare

Zejula 100 mg Alternative – Nirova (Niraparib) 100 mg Capsule | Beacon Pharmaceuticals

Nirova 100 mg (Niraparib) Capsule by Beacon Pharmaceuticals. Reference brand: Zejula. PARP inhibitor; used in selected ovarian cancer maintenance settings. Prescription medicine. Brand comparison does not establish interchangeability.

Add to wishlist
Read more
Quick view
Beacon Zytix 250 mg abiraterone tablet packaging, alongside 500 mg variant
Compare

Zytiga 250 mg Alternative – Zytix (Abiraterone Acetate) 250 mg Tablet | Beacon Pharmaceuticals

Zytix 250 mg (Abiraterone Acetate) Tablet by Beacon Pharmaceuticals. Reference brand: Zytiga. androgen synthesis inhibitor; used in selected advanced prostate cancer with corticosteroid therapy. Prescription medicine. Brand comparison does not establish interchangeability.

Add to wishlist
Read more
Quick view